Busulfan analysis with quantitative UPLC-MS/MS for clinical research

Achieve rapid analysis and increased sensitivity

Traditional analytical methods encounter challenges when quantifying busulfan, an antineoplastic cancer therapy, due to its bioavailability. UPLC-MS/MS analysis with the ACQUITY UPLC I-Class PLUS and Xevo TQD Mass Spectrometer provides clinical research laboratories with highly selective and accurate data, as well as and rapid analysis and increased sensitivity.

見積もり依頼
  • 概要
  • 関連製品情報
  • アプリケーションノート
`

お問い合わせはこちら

見積もり依頼

企業情報